Privia Health Group, Inc. (PRVA): Operating Cash Flow
$163.40M
Year ended 2025-12-31
$131.13M
Trailing 12 months to 2026-06-30
+51.3%
3-year compound annual growth
+33.3%
5-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $163.40M | +49.5% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $109.28M | +35.3% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $80.78M | +71.2% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $47.20M | -14.3% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $55.06M | +41.6% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $38.89M | +59.7% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $24.36M | n/a | 2022-03-25, From 2019-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | 2025-12-31 | $163.40M | +49.5% |
| P3 Health Partners Inc. (PIII) | 2025-12-31 | -$91.24M | n/m |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $146.15M | +36.3% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $64.71M | +96.9% |
| Pennant Group, Inc. (PNTG) | 2025-12-31 | $48.29M | +22.9% |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $75.06M | +0.2% |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $33.28M | n/m |
| DocGo Inc. (DCGO) | 2025-12-31 | $34.45M | -50.9% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | $18.25M | n/m |
Compare PRVA, PIII, LFST, INNV side by side · Screen every company in Services-Health Services ↗